Performance and Accuracy of an AI Enhanced Smart Watch Single Lead ECG

NCT05450809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-12-28

No results posted yet for this study

Summary

The purpose of this study is to show the artificial intelligence enhanced single-lead ECG Apple Watch has similar, robust performance comparable to an AI enhanced 12 lead ECG and AI enhanced single lead (LI) of a 12 lead ECG.

Conditions

  • Healthy

Sponsors & Collaborators

Principal Investigators

  • Itzhak Zachi Attia, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-05
Primary Completion
2022-11-02
Completion
2022-11-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05450809 on ClinicalTrials.gov